Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs NP2GO

Fierce Health
Graded #410

Lower grade

vs+23.6
NP2GO
Graded #37

Higher grade

The verdict

NP2GO takes it — 80.2/100 to 56.6/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +48
33
81
Dose & formulationNP2GO +3
77
80
Clinical oversightNP2GO +17
62
79
Labs & monitoringNP2GO +26
52
78
FulfillmentNP2GO +7
75
82
Contract termsNP2GO +35
47
82
Fierce Health · left barNP2GO · right bar

The numbers

MetricFierce HealthNP2GO
WeighScore56.6/10080.2/100
GradeCB−
Scorecard rank#410#37
Semaglutide$297/mo (3-month plan, compounded)$150/mo
Tirzepatide$497/mo (3-month plan, compounded)$250/mo
Coverage30 states40 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Fierce Health

Graded #410 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

Where it loses points

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard